{"id":198928,"date":"2022-06-30T00:00:00","date_gmt":"2022-06-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/manpq9422-digital-physician-multichannel-insights-2022-phase-i-2\/"},"modified":"2026-03-31T14:27:26","modified_gmt":"2026-03-31T14:27:26","slug":"manpq9422-digital-physician-multichannel-insights-2022-phase-i-taking-the-pulse-us-medical-oncologists","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/manpq9422-digital-physician-multichannel-insights-2022-phase-i-taking-the-pulse-us-medical-oncologists\/","title":{"rendered":"Physician Multichannel Insights | 2022 | Phase I | Taking the Pulse | US | Medical Oncologists | Segmentation"},"content":{"rendered":"<p><strong>Physician Multichannel Insights | 2022 | Phase I | Taking the Pulse | US | Medical Oncology: (Segmentation Reference Data Deck)<\/strong><\/p>\n<p>Our 2022 Study among physicians provides significantly more detailed insights on the information seeking behaviors (content needs and channel preferences) of both, primary care physicians and key specialists.<\/p>\n<p>To provide this greater level of details, our physician study runs in two different phases, each covering different topics, and each phase producing a separate\u00a0<em>specialty-specific report<\/em>.<\/p>\n<p>Phase I or\u00a0<em>Taking the Pulse<\/em>, was fielded during March-June 2022 and it explores the circumstances when physicians look for Product, Medical and Patient information and\/or services. It also explores how these types of content impact clinical decisions, with insights aligned to the key conditions each type of specialty treat.<\/p>\n<p><strong>Topics covered within Phase I &#8211; Taking the Pulse\u00ae<\/strong><\/p>\n<p><strong>Information-seeking behaviors<\/strong><\/p>\n<ul>\n<li>Circumstances in which specialists need and seek out information<\/li>\n<li>Information and services needed in each circumstance<\/li>\n<li>Formats and attributes preferred for each type of content\/services<\/li>\n<li>Channels preferred to access each type of content\/services<\/li>\n<\/ul>\n<p><strong>Patient-care interactions<\/strong><\/p>\n<ul>\n<li>Information needs at key decision making points: immediately before, during, and after patient consultations<\/li>\n<li>Messaging conversion driving specialists to take specific actions after accessing each content type<\/li>\n<li>Patient requests, needs and outcomes from providing valued information support during physician patient consultations<\/li>\n<\/ul>\n<p><strong>Disease-level insights<\/strong><\/p>\n<ul>\n<li>Physician-identified challenges in diagnosis and treatment of the patient conditions they treat, and factors affecting these challenges<\/li>\n<li>Severity of unmet need around each disease-specific challenge identified<\/li>\n<li>Information and service needs at the point of care that would help physicians address unmet needs and inform referral or prescribing behavior<\/li>\n<li>Treatment uptake, experiences, and adherence\/switching factors for specific treatments by condition<\/li>\n<li>Information and service needs among physicians to support patients in managing their condition and lifestyle<\/li>\n<\/ul>\n<p><strong>Refer to our Phase II or<em>\u00a0Re-Taking the Pulse<\/em>\u00a0for more details on the topics covered within those reports.<\/strong><\/p>\n<p>This report contains the underlying data from Phase I \u2013 Taking the Pulse specific to US Medical Oncologists (n=83) with insights aligned to the following conditions:<\/p>\n<ul>\n<li>Small cell lung cancer (SCLC)<\/li>\n<li>Squamous cell carcinoma of the head and neck (SCCHN)<\/li>\n<li>Hepatocellular carcinoma (HCC)<\/li>\n<li>Esophageal cancer<\/li>\n<li>Renal cell carcinoma (RCC)<\/li>\n<li>Bladder cancer<\/li>\n<li>Pancreatic cancer<\/li>\n<li>Gastric cancer<\/li>\n<li>Neuroendocrine tumor (NET)<\/li>\n<li>Cervical cancer<\/li>\n<li>Endometrial cancer<\/li>\n<li>Glioma<\/li>\n<li>Non-small cell lung cancer (NSCLC)<\/li>\n<li>Colorectal cancer<\/li>\n<li>Malignant melanoma<\/li>\n<li>Prostate cancer<\/li>\n<li>Breast cancer<\/li>\n<li>Ovarian cancer<\/li>\n<\/ul>\n","protected":false},"template":"","class_list":["post-198928","report","type-report","status-publish","hentry","report-gateway-digital","digital-audience-type-physicians","digital-segmentation-segmentation","digital-study-name-taking-the-pulse","digital-date-966"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/198928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/198928\/revisions"}],"predecessor-version":[{"id":287165,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/198928\/revisions\/287165"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=198928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}